Kanker/Misselijkheid & Overgeven:

Jatoi A., Windschitl H.E., Loprinzi C.L., Sloan J.A., Dakhil S.R., Mailliard J.A., Pundaleeka S., Kardinal C.G., Fitch T.R., Krook J.E., Novotny P.J., Christensen B. (2002). Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. Journal of Clinical Oncology;20(2):567-573
THC/ oraal

Soderpalm A.H., Schuster A., de Wit H. (2001). Antiemetic efficacy of smoked marijuana: subjective and behavioral effects on nausea induced by syrup of ipecac. Pharmacology, Biochemistry and Behavior ;69(3-4):343-350.

Cannabis/ inhalatie

Gonzalez-Rosales F., Walsh D. (1997). Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol). Journal of Pain and Symptom Management;14(5):311-314
THC/ oraal

Schwartz R.H., Voth E.A., Sheridan M.J. (1997). Marijuana to prevent nausea and vomiting in cancer patients: a survey of clinical oncologists. South Medical Journal. Feb;90(2):167-72.
Cannabis

Abrahamov A., Abrahamov A., Mechoulam R. (1995). An efficient new cannabinoid antiemetic in pediatric oncology. Life Sciences;56(23-24):2097-2102 
THC/ oraal

Nelson K., Walsh D., Deeter P., Sheehan F. (1994). A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Journal of Palliative Care;10(1):14-18
THC/ oraal

Lewis I.H., Campbell D.N., Barrowcliffe M.P. (1994). Effect of nabilone on nausea and vomiting after total abdominal hysterectomy. British Journal of Anaesthesia Aug;73(2):244-6. 
Nabilone/ oraal

Lane M., Vogel C.L., Ferguson J., Krasnow S., Saiers J.L., Hamm J. (1991). Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting. Journal of Pain and Symptom Management;6:352-359
THC/ oraal

Doblin R.E., Kleiman M.A. (1991). Marijuana as antiemetic medicine: a survey of oncologists' experiences and attitudes. American Journal of Clinical Oncology Jul;9(7):1314-9.
Cannabis/ inhalatie

Wadleigh R, Spaulding GM, Lumbersky B, Zimmer M, Shepard K, Plasse T (1990). Dronabinol enhancement of appetite in cancer patients. Proc Am Soc Oncology;9:331.
THC/ oraal

McCabe M., Smith F.P., Goldberg D., Macdonald J., Woolley P.V., Warren R. (1988). Efficacy of tetrahydrocannabinol in patients refractory to standard anti-emetic therapy. Investigational New Drugs;6:243-246 
THC/ oraal

Cunningham D., Bradley C.J., Forrest G.J., Hutcheon A.W., Adams L., Sneddon M., Harding M., Kerr D.J., Soukop M., Kaye S.B. (1988). A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues. European Journal of Cancer and Clinical Oncology Apr;24(4):685-9. 
Nabilone/ oraal

Vinciguerra V., Moore T., Brennan E. (1988). Inhalation marijuana as an antiemetic for cancer chemotherapy. New York State Journal of Medicine;88:525-527.
Cannabis/ inhalatie

Chan H.S., Correia J.A., MacLeod S.M. (1987). Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial. Pediatrics. Jun;79(6):946-52.
Nabilone/ oraal

Priestman S.G., Priestman T.J., Canney P.A. (1987). A double-blind randomised cross-over comparison of nabilone and metoclopramide in the control of radiation-induced nausea Clinical Radiology Sep;38(5):543-4. 
Nabilone/ oraal

?Crawford S.M., Buckman R. (1986). Nabilone and metoclopramide in the treatment of nausea and vomiting due to cisplatinum: a double blind study. Medical Oncology and Tumor Pharmacotherapy; 3(1):39-42. 
Nabilone/ oraal

Dalzell A.M., Bartlett H., Lilleyman J.S. (1986). Nabilone: an alternative antiemetic for cancer chemotherapy. Archives of Disease in Childhood May;61(5):502-5.
Nabilone/ oraal

Niederle N., Schutte J., Schmidt C.G. (1986). Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy. Klinische Wochenschrift Apr 15;64(8):362-5. 
Nabilone/ oraal

?Pomeroy M., Fennelly J.J., Towers M. (1986). Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis. Cancer Chemotherapy and Pharmacology;17(3):285-8. 
Nabilone/ oraal

Ungerleider J.T., Sarna G., Fairbanks L.A., Goodnight J., Andrysiak T., Jamison K. (1985). THC or Compazine for the cancer chemotherapy patient--the UCLA study. Part II: Patient drug preference. American Journal of Clinical Oncology; 8: 142-147. 
THC/ oraal

Niiranen A., Mattson K. (1985). A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy. Ameran Journal of Clinical Oncology; Aug;8(4):336-40. 
Nabilone/ oraal

Levitt M., Faiman C., Hawks R., Wilson A. (1984). Randomized double blind comparison of delta-9-tetrahydroicannabinol (THC) and marijuana as chemotherapy antiemetics. Proceedings of the American Society for Clinical Oncology; 3:91.
Cannabis & THC/ inhalatie & oraal

Ungerleider J.T., Andrysiak T., Fairbanks L., Goodnight J., Sarna G., Jamison K. (1982). Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine. Cancer ;50:636-645.
THC/ oraal

Chang A.E., Shiling D.J., Stillman R.C., Goldberg N.H., Seipp C.A., Barofsky I., Rosenberg S.A. (1981). A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy. Cancer;47(7):1746-51.
THC/ oraal & inhalatie

Levitt M., Wilson A., Bowman D., Faiman C., Kemel S., Krepart G. (1981). Dose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy antiemetics. Proceedings of the American Society for Clinical Oncology;22:422. 
THC/ oraal

Neidhart J.A., Gagen M.M., Wilson H.E., Young D.C. (1981). Comparative trial of the antiemetic effects of THC and haloperidol International Journal of Clinical Pharmacology Research; 21: 38-42S.
THC/ oraal

Levitt M., Wilson A., Bowman D., Kemel S., Krepart G., Marks V., Schipper H., Thomson G., Weinerman B., Weinerman R. (1981). Physiologic observations in a controlled clinical trial of the antiemetic effectiveness of 5, 10, and 15 mg of delta 9-tetrahydrocannabinol in cancer chemotherapy. Ophthalmologic implications. Journal of Clinical Pharmacology;21(8-9 Suppl):103S-109S.
THC/ oraal

Sallan S.E., Cronin C., Zelen M., Zinberg N.E. (1980). Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. New England Journal of Medicine; 302(3):135-138. 
THC/ oraal

Orr L.E., McKernan J.F., Bloome B. (1980). Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis. Annals of Internal Medicine;140(11):1431-1433. 
THC/ oraal

Frytak S., Moertel C.G., O'Fallon J.R., Rubin J., Creagan E.T., O'Connell M.J., Schutt A.J., Schwartau N.W. (1979). Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo. Annals of Internal Medicine ;91(6):825-830. 
THC/ oraal

Chang A.E., Shiling D.J., Stillman R.C., Goldberg N.H., Seipp C.A., Barofsky I., Simon R.M., Rosenberg S.A. (1979). Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation. Annals of Internal Medicine;91:819-824. 
THC/ oraal

Kluin-Nelemans J.C., Nelemans F.A., Meuwissen O.J.A.Th., Maes R.A.A. (1979).? Delta-9-tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancer chemotherapy; a double-blind cross-over trial against placebo Veterinary and Human Toxicology ;21:338-340.

THC/ oraal

Ekert H., Waters K.D., Jurk I.H., Mobilia J., Loughnan P. (1979). Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol. Medical Journal of Australia: Dec 15;2(12):657-9.

THC/ oraal

Sallan S.E., Zinberg N.E., Frei E. (1975). Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. New England Journal of Medicine ;293(16):795-797.

THC/ oraal

Noyes R. Jr, Brunk S.F., Baram D.A., Canter A. (1975) Analgesic effect of delta-9-tetrahydrocannabinol. Journal of Clinical Pharmacology ;15(2-3):139-143.

THC/ oraal

Noyes R. Jr, Brunk S.F., Avery D.A.H., Canter A.C. (1975). The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clinical Pharmacology and Therapeutics;18(1):84-89.
THC/ oraal